Related Experiment Videos

[Cholesterol embolism after percutaneous transluminal coronary angioplasty procedure: a case report]

T Sakamoto1, N Inoue, K Kunitomo

  • 1Department of Cardiology, Kyoto Second Red Cross Hospital, Kyoto.

Journal of Cardiology
|March 21, 2001
PubMed

Insights

Cholesterol embolism is a rare complication following cardiac procedures like angioplasty. This case highlights its delayed diagnosis and fatal outcome, emphasizing the need for awareness.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Pathology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) with stent implantation is a common intervention for angina pectoris.
  • Femoral artery access is frequently used for coronary angiography and interventional procedures.

Observation:

  • A 68-year-old male developed renal dysfunction and purpura on his feet approximately one month after PTCA.
  • Symptoms progressed to severe renal failure, leading to hospitalization and death from multiple organ failure two months later.
  • Autopsy confirmed cholesterol embolism as the cause of multi-organ failure.

Findings:

  • Cholesterol embolism is a rare but serious complication of angiographic and interventional procedures.
  • Clinical diagnosis of cholesterol embolism can be challenging, often presenting with delayed symptoms.
  • Crystal emboli were identified in multiple organs during post-mortem examination.

Implications:

  • Increased frequency of interventional cardiology procedures may lead to a rise in cholesterol embolism cases.
  • Early recognition and diagnosis of cholesterol embolism are crucial for potential management, despite the lack of established therapies.
  • Further research into diagnostic markers and therapeutic strategies for cholesterol embolism is warranted.

Related Concept Videos